ClinicalTrials.Veeva

Menu

Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP (RECAP-5)

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Aspirin-exacerbated Respiratory Disease
Nasal Polyps

Treatments

Other: Non-Interventional

Study type

Observational

Funder types

Other

Identifiers

NCT05672030
2003P002088

Details and patient eligibility

About

The overarching hypothesis of this proposal is that IL-5 acts on multiple sinus tissue cell types, including plasma cells and epithelial cells, to promote immune dysregulation, and that inhibition of IL-5 affects several relevant effector pathways that lead to clinical benefit.

Full description

Further characterization of the role of IL-5Rα expression and function on human plasma cells will determine whether inhibiting IL-5 signaling on these cells offers therapeutic promise in other diseases related to plasma cell proliferation. Further characterization of human upper airway epithelial cell IL-5Rα expression and function will determine whether or not inhibiting IL-5 signaling on these cells offers therapeutic promise in other diseases related to epithelial dysfunction. IL-5Rα expression has been identified on several relevant sinus tissue effector cells, including on nasal polyp plasma cells and epithelial cells, and the aim of this study is to further the field by determining the consequences of IL-5 signaling on those cells.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • AERD, CRSwNP, healthy controls

Exclusion criteria

  • Not on any systemic steroids or respiratory biologics at time of surgery

Trial design

30 participants in 3 patient groups

Aspirin-exacerbated respiratory disease (AERD)
Description:
Aspirin-exacerbated respiratory disease (AERD)
Treatment:
Other: Non-Interventional
Aspirin-tolerant chronic rhinosinusitis with nasal polyps (CRSwNP)
Description:
Aspirin-tolerant chronic rhinosinusitis with nasal polyps (CRSwNP)
Treatment:
Other: Non-Interventional
Healthy controls
Description:
Individuals who do not have AERD or CRSwNP
Treatment:
Other: Non-Interventional

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Tanya M Laidlaw; Tessa Ryan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems